PMDA registration
Novartis Gene Therapies, Inc.
PMDA registration FG30410026 · USA
Key facts
| Registration number | FG30410026 |
|---|---|
| Site | Novartis Gene Therapies, Inc. |
| Corporation | Novartis Gene Therapies, In. |
| Country | USA |
| Type of business | Foreign manufacturers of regenerative medicine products |
| Registration categories | Regenerative medicine products general |
| Registered | Jun 1, 2023 |
| Expires | May 31, 2028 |
At a glance
- None PMDA inspections
- No Registration expired
- No Registration abolished
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA registered foreign manufacturers (Japan)
Foreign manufacturers of drugs and medical devices supplied to Japan must be registered (accredited) with the Ministry of Health, Labour and Welfare through the PMDA.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan